The Institute of Biotechnology (BI) is a dynamic unit with the mission to conduct research and develop infrastructures in biotechnology and modern biosciences. BI addresses global questions on sustainable environment and the well-being of living organisms; it operates in a wide scientific landscape from plants and microbes to seals and molecular pathogenesis and treatment of human diseases.
The Institute of Biotechnology operates at the highest international level and its researchers have been very successful in obtaining e.g. ERC grants and Academy of Finland Center of Excellence funding. Research in BI spans from fundamental research to applied biotechnology and includes cytoskeletal and membrane dynamics; morphogenesis, stem cells and regeneration; plant, animal, microbial genomics and evolution; mechanisms of redox systems; and structure of membrane protein complexes.
BI has pioneered the development of Finland’s life science research infrastructures and currently houses core facilities for biological imaging, proteomics, NMR, protein crystallization, genomics, and bioinformatics.
The research findings are actively applied for the benefit of society through valorisation of innovations and start-ups. Several success stories including Herantis Pharma Ltd and Mobidiag Ltd originate from the institute.